Sanofi Made False Claims About RSV Shot for Infants, FDA Says

In a letter to the drugmaker, the FDA said the agency approved Beyfortus, an RSV monoclonal antibody, as a defense against RSV lower respiratory tract disease — but that Sanofi has been claiming it protects broadly against RSV disease, which occurs in the lower and upper tracts. Beyfortus has come […]

The post Sanofi Made False Claims About RSV Shot for Infants, FDA Says appeared first on Activist Post.